Author Archives: Shane Whitney

April 2019 Abstract Roundup

CHRONIC KIDNEY DISEASE Possible Beneficial Effect of Statin Therapy on Iron Metabolism in Patients with CKD Renal Failure. doi:10.1080/0886022X.2018.1535983 Anna Masajtis-Zagajewska, MD, PhD, and colleagues conducted a double blind, randomized crossover study designed to examine the effect of 6-month administration of atorvastatin on hepcidin and hemojuvelin levels, inflammatory parameters, and iron metabolism in patients with chronic kidney disease (CKD) stages ... Read More »

April 2019 News Briefs

WavelinQ™ 4F EndoAVF System Receives 510(k) Clearance from FDA In February, BD (Becton, Dickinson and Company), a global medical technology company, received 510(k) clearance from the US Food and Drug Administration for the BD WavelinQ™ 4 French (4F) endoAVF system. The system is a recent innovation in endovascular arteriovenous fistula (endoAVF) creation technology; it allows for the creation of an ... Read More »

From the Field: New Frequency of Hemodialysis Local Coverage Determinations

Sarah Tolson Effective March 1, 2019, several Medicare Administrative Contractors (MACs) began processing claims for hemodialysis treatments under new Local Coverage Determinations (LCDs). These LCDs underwent massive revisions after the proposed LCDs released in 2017 would have essentially eliminated reimbursement for more than three treatments per week because they were so strict. Medicare, the largest payer in the United States ... Read More »

Underuse of Oral Anticoagulation and Overuse of Aspirin in Atrial Fibrillation Patients with CKD

New Orleans—There is an association between renal function and outcomes of patients receiving anticoagulation treatment for atrial fibrillation. Michael Dorsch, MS, PharmD, and colleagues conducted an analysis to test the hypothesis that there are changes in prescribing patterns of oral anticoagulants and clinical outcome based on chronic kidney disease (CKD) status. Results of the analysis were presented during a poster ... Read More »

Urinary Oxalate Excretion Associated with Risk of Progression of CKD and ESRD

San Diego—Oxalate nephropathy, a complication of oxalate metabolism (primary hyperoxaluria), oxalate over-absorption (enteric hyperoxaluria), and ingestion of large amounts of oxalate or its precursors, results in kidney failure. Sushrut S. Waikar, MD, and colleagues conducted an analysis to test the hypothesis that there would be an association between progression of chronic kidney disease (CKD) and higher urinary oxalate excretion, even ... Read More »

Post Hoc Analysis: Patiromer Safe and Effective in Patients with Diabetes Mellitus

San Diego—Researchers, led by Patrick Rossignol, MD, PhD, recently conducted a post-hoc pooled analysis to examine the efficacy and safety of patiromer for the treatment of hyperkalemia in patients with and without diabetes mellitus. The researchers reported results of the analysis during a poster session at Kidney Week 2018 in a poster titledEfficacy and Safety of Patiromer in Participants with ... Read More »

Use of a Patient Portal Decreases Hospital Admission Rates

San Diego–Clinical status of patients on peritoneal dialysis are commonly assessed only once a month, limiting the clinician’s view of the state of the patient’s health. A large dialysis provider has launched a connected health program to enable patients on peritoneal dialysis to enter their clinical parameters or concerns daily. The portal provides automated alerts to clinicians for abnormal findings; ... Read More »